These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 34988855

  • 1. Linagliptin ameliorates pulmonary fibrosis in systemic sclerosis mouse model via inhibition of endothelial-to-mesenchymal transition.
    Pei B, Zhang N, Pang T, Sun G.
    Mol Cell Biochem; 2022 Apr; 477(4):995-1007. PubMed ID: 34988855
    [Abstract] [Full Text] [Related]

  • 2. Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition.
    Suzuki T, Tada Y, Gladson S, Nishimura R, Shimomura I, Karasawa S, Tatsumi K, West J.
    Respir Res; 2017 Oct 16; 18(1):177. PubMed ID: 29037205
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic effects of adipose-derived mesenchymal stem/stromal cells with enhanced migration ability and hepatocyte growth factor secretion by low-molecular-weight heparin treatment in bleomycin-induced mouse models of systemic sclerosis.
    Suzuka T, Kotani T, Saito T, Matsuda S, Sato T, Takeuchi T.
    Arthritis Res Ther; 2022 Oct 07; 24(1):228. PubMed ID: 36207753
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosis.
    Mor A, Segal Salto M, Katav A, Barashi N, Edelshtein V, Manetti M, Levi Y, George J, Matucci-Cerinic M.
    Ann Rheum Dis; 2019 Sep 07; 78(9):1260-1268. PubMed ID: 31129606
    [Abstract] [Full Text] [Related]

  • 14. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
    Lei L, He ZY, Zhao C, Sun XJ, Zhong XN.
    Int J Rheum Dis; 2016 Apr 07; 19(4):392-404. PubMed ID: 25545680
    [Abstract] [Full Text] [Related]

  • 15. Epicatechin protective effects on bleomycin-induced pulmonary oxidative stress and fibrosis in mice.
    Shariati S, Kalantar H, Pashmforoosh M, Mansouri E, Khodayar MJ.
    Biomed Pharmacother; 2019 Jun 07; 114():108776. PubMed ID: 30903918
    [Abstract] [Full Text] [Related]

  • 16. Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis.
    Kondo M, Suzuki T, Kawano Y, Kojima S, Miyashiro M, Matsumoto A, Kania G, Błyszczuk P, Ross RL, Mulipa P, Del Galdo F, Zhang Y, Distler JHW.
    Arthritis Res Ther; 2022 Sep 01; 24(1):210. PubMed ID: 36050717
    [Abstract] [Full Text] [Related]

  • 17. Effects of thalidomide on Th17, Treg cells and TGF-β1/Smad3 pathway in a mouse model of systemic sclerosis.
    Lu Y, Zhao C, Lei L, Tao Z, Zheng L, Wen J, Li X.
    Int J Rheum Dis; 2020 Mar 01; 23(3):406-419. PubMed ID: 31840939
    [Abstract] [Full Text] [Related]

  • 18. The dipeptidyl peptidase-4 inhibitor linagliptin ameliorates LPS-induced acute lung injury by maintenance of pulmonary microvascular barrier via activating the Epac1/AKT pathway.
    Zhang N, Tang S, Zhang J, Pei B, Pang T, Sun G.
    Biomed Pharmacother; 2022 Nov 01; 155():113704. PubMed ID: 36115114
    [Abstract] [Full Text] [Related]

  • 19. Vildagliptin, a CD26/DPP4 inhibitor, ameliorates bleomycin-induced pulmonary fibrosis via regulating the extracellular matrix.
    Liu Y, Qi Y.
    Int Immunopharmacol; 2020 Oct 01; 87():106774. PubMed ID: 32731178
    [Abstract] [Full Text] [Related]

  • 20. Bone morphogenetic protein-7 inhibits endothelial-to-mesenchymal transition in primary human umbilical vein endothelial cells and mouse model of systemic sclerosis via Akt/mTOR/p70S6K pathway.
    Shen C, Jiang Y, Li Q, Liu C, Hu F, Li M.
    J Dermatol Sci; 2021 Aug 01; 103(2):82-92. PubMed ID: 34266726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.